The epidemiology of bacterial sepsis

被引：80

作者：

Rangel-Frausto, MS

机构：

[1] Inst Nacl Nutr Salvador Zubiran, Div Hosp Epidemiol, Mexico City 14000, DF, Mexico

[2] Natl Med Ctr, Hosp Epidemiol Res Unit, Mexico City, DF, Mexico

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 1999年 / 13卷 / 02期

关键词：

D O I：

10.1016/S0891-5520(05)70076-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

As a result of better understanding of pathogenesis, new definitions of sepsis have been proposed, and the complexity of this syndrome is clearer. Population-based studies of bloodstream infections-what now is called sepsis-have helped us to understand the natural history of this very frequent problem. The mortality and morbidity of each of the systemic inflammatory response syndrome stages have been described; our ability to better understand and predict these stages will help us to make better therapeutic decisions.

引用

页码：299 / +

页数：15

共 55 条

[1] Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania [J].

Archibald, LK ;

den Dulk, MO ;

Pallangyo, KJ ;

Reller, LB .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :290-296

[2] Predicting bacteremia in patients with sepsis syndrome [J].

Bates, DW ;

Sands, K ;

Miller, E ;

Lanken, PN ;

Hibberd, PL ;

Graman, PS ;

Schwartz, JS ;

Kahn, K ;

Snydman, DR ;

Parsonnet, J ;

Moore, R ;

Black, E ;

Johnson, BL ;

Jha, A ;

Platt, R .

JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1538-1551

[3] THE MARKOV PROCESS IN MEDICAL PROGNOSIS [J].

BECK, JR ;

PAUKER, SG .

MEDICAL DECISION MAKING, 1983, 3 (04) :419-458

[4]

BISBE J, 1988, REV INFECT DIS, V10, P629

[5]

Bone R C, 1991, Infect Dis Clin North Am, V5, P793

[6] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].

BONE, RC ;

BALK, RA ;

CERRA, FB ;

DELLINGER, RP ;

FEIN, AM ;

KNAUS, WA ;

SCHEIN, RMH ;

SIBBALD, WJ ;

ABRAMS, JH ;

BERNARD, GR ;

BIONDI, JW ;

CALVIN, JE ;

DEMLING, R ;

FAHEY, PJ ;

FISHER, CJ ;

FRANKLIN, C ;

GORELICK, KJ ;

KELLEY, MA ;

MAKI, DG ;

MARSHALL, JC ;

MERRILL, WW ;

PRIBBLE, JP ;

RACKOW, EC ;

RODELL, TC ;

SHEAGREN, JN ;

SILVER, M ;

SPRUNG, CL ;

STRAUBE, RC ;

TOBIN, MJ ;

TRENHOLME, GM ;

WAGNER, DP ;

WEBB, CD ;

WHERRY, JC ;

WIEDEMANN, HP ;

WORTEL, CH .

CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874

[7] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].

BONE, RC ;

FISHER, CJ ;

CLEMMER, TP ;

SLOTMAN, GJ ;

METZ, CA ;

BALK, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658

[8] SEPSIS SYNDROME - A VALID CLINICAL ENTITY [J].

BONE, RC ;

FISHER, CJ ;

CLEMMER, TP ;

SLOTMAN, GJ ;

METZ, CA ;

BALK, RA .

CRITICAL CARE MEDICINE, 1989, 17 (05) :389-393

[9] Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J].

Bone, RC .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (08) :680-687

[10] SEPSIS, THE SEPSIS SYNDROME, MULTIORGAN FAILURE - A PLEA FOR COMPARABLE DEFINITIONS [J].

BONE, RC .

ANNALS OF INTERNAL MEDICINE, 1991, 114 (04) :332-333

← 1 2 3 4 5 6 →